Sharemaestro Newsreel

Baird Medical and Alpmed Enter Strategic Partnership to Advance Irreversible Electroporation (IRE) Technology Globally

Baird Medical Investment Holdings Ltd. and Tianjin Yuanshan Medical Technology Co., Ltd. (Alpmed) have formed a strategic partnership to develop and commercialize next-generation irreversible electroporation (IRE) technologies globally. This collaboration aims to combine Alpmed's IRE innovation with Baird Medical's regulatory and commercialization expertise, with …

Artivion revenue up 11% to USD 125.8M in Q2 2026

Artivion, Inc. reported an 11% increase in total revenues to $125.8 million for Q2 2026, driven by strong growth in On-X and stent grafts. The company also announced the acquisition of Endospan Ltd. and U.S. FDA approval for its AMDS Hybrid Prosthesis, strengthening its …

Glaukos Corporation (GKOS) Stock Analysis: Target Price Insights And Growth Prospects

Glaukos Corporation (GKOS) is a prominent healthcare company specializing in medical devices for eye disorders, currently priced at $180.02. Despite a high forward P/E ratio of 358.64 and negative profitability metrics, the company shows robust revenue growth of 49.50% and strong analyst sentiment with …

Glaukos (GKOS) Q2 2026 Earnings Call Transcript

Glaukos (GKOS) reported record second-quarter 2026 net sales of $185.6 million, a 50% increase year-over-year, driven by strong adoption of iDose TR and the launch of Epioxa. The company raised its full-year 2026 net sales guidance to $680 million to $700 million and provided …

Bruker takes majority stake in organ-on-a-chip firm MIMETAS

Bruker Corporation has acquired a majority stake in MIMETAS B.V., a company specializing in organ-on-a-chip platforms and human tissue models for drug discovery. This investment will allow Bruker to integrate MIMETAS' OrganoPlate platform with its existing technologies, expanding its offerings in Microphysiological Systems. MIMETAS …

Quanterix (NASDAQ:QTRX) Announces Quarterly Earnings Results

Baird Medical partners with Alpmed on ablation technology

Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) has announced a strategic cooperation agreement with Tianjin Yuanshan Medical Technology Co., Ltd. (Alpmed) to develop and commercialize irreversible electroporation (IRE) technologies globally. This partnership aims to combine Alpmed’s IRE expertise with Baird Medical’s regulatory and commercialization capabilities, …

Quanterix Q2 2026 earnings: Revenue rises 34% as outlook is cut

Quanterix (QTRX) reported a 34% rise in Q2 2026 revenue to $32.9 million, primarily driven by product sales. Despite a narrower adjusted EBITDA loss, the GAAP net loss widened significantly to $48.9 million due to a $26.9 million Akoya-related goodwill impairment. The company cut …

Quanterix Corp 2026: Revenue $32.91M, EPS ($1.04) — 10-Q Summary

Quanterix Corp (QTRX) reported its financial results for the quarter ended 2026, with revenues reaching $32.91 million and a net loss of $48.93 million, resulting in a diluted loss per share of $1.04. This represents a significant increase in revenue and net loss compared …

Quanterix Names Jim Gute Chief Commercial Officer to Accelerate Growth

Quanterix Corporation has appointed Jim Gute as Chief Commercial Officer to lead its commercial operations. Gute will focus on expanding the company's customer base, increasing the utilization of its installed systems, and strengthening commercial execution as Quanterix prepares to grow its diagnostics business and …

Quanterix (QTRX) boosts revenue as Alzheimer’s bets rise amid big write-downs

Quanterix reported a 34% increase in Q2 2026 revenue to $32.9 million, largely driven by the acquisition of Akoya Biosciences, but also recorded significant net losses of $48.9 million due to substantial goodwill and R&D impairments. The company is strategically shifting its focus towards …

Stifel cuts RxSight stock price target on competitive headwinds

Stifel lowered its price target for RxSight Inc. (NASDAQ:RXST) to $7.00 from $8.00 due to competitive headwinds, while maintaining a Hold rating. Despite the stock appearing undervalued and recent Q2 2026 earnings beating expectations, the company withdrew its full-year guidance. Stifel anticipates a turnaround …

Is Varex Imaging Corp (VREX) Undervalued After Q3 Earnings Beat?

Envoy Medical (NASDAQ: COCH) burns cash on Acclaim implant trial after $28M raise

Zimmer Biomet (NYSE:ZBH) Price Target Raised to $100.00

Canaccord Genuity raised Zimmer Biomet's (NYSE:ZBH) price target from $83.00 to $100.00 while maintaining a "hold" rating, suggesting a 3.59% upside. The medical equipment provider recently reported strong quarterly earnings, beating EPS estimates by $0.06 and achieving a 4.8% year-over-year revenue increase. Analysts, on …

VAREX IMAGING (VREX) Q3 Earnings Beat Estimates

VAREX IMAGING (VREX) came out with quarterly earnings of $0.31 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.18 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an …

Nanox.AI Optimizes Medical Imaging AI Application Framework for Intel Core Ultra Processors with OpenVINO

On-premise medical imaging AI framework uses Intel Core Ultra processors and Intel’s OpenVINO toolkit to accelerate edge inference within healthcare environments PETACH TIKVA, Israel – August 10 – Nanox AI Ltd., a subsidiary of Nano-X Imaging Ltd. (NASDAQ: NNOX), today announced the optimization of …

Varex Imaging (NASDAQ:VREX) Issues Earnings Results

Boston Scientific announces participation in Wells Fargo 21st Annual Healthcare Conference and conference call discussing third quarter 2026 results

Boston Scientific (BSX) will participate in Wells Fargo's 21st Annual Healthcare Conference on September 10, 2026, with Mike Mahoney and Kenneth Stein, M.D., leading a Q&A session. The company will also webcast its third-quarter 2026 earnings call on October 28, 2026, hosted by Mike …

Envoy Medical (COCH) Announces Q2 2026 Earnings, Files Initial FDA PMA Module, and Reveals Strong Clinical Results for Acclaim® Cochlear Implant

Teledyne to acquire Varex Imaging for $1.1 billion in cash

Teledyne Technologies Incorporated announced its definitive agreement to acquire Varex Imaging Corporation for $1.1 billion in cash, including equity awards and net debt. The deal, unanimously approved by both boards, will see Teledyne pay $18.90 per share. Varex, a developer of X-ray sources and …

Varex Imaging (VREX) swings to Q3 profit with margin gains and tariff refund boost

Varex Imaging (VREX) reported a swing to profit in Q3 fiscal 2026, with GAAP net income of $15.7 million compared to a significant loss a year prior. The company saw a 4% year-over-year increase in total revenue to $210.5 million, boosted by a $17 …

Why Viemed Healthcare's (NASDAQ:VMD) Earnings Are Better Than They Seem

Viemed Healthcare's recent earnings, despite seemingly weak stock performance, are better than they appear due to strong cash conversion. The company recorded a negative accrual ratio of -0.11, indicating its free cash flow of US$29m significantly exceeded its statutory profit of US$14.5m. Additionally, unusual …

Establishment Labs Holdings Inc. (NASDAQ:ESTA) Released Earnings Last Week And Analysts Lifted Their Price Target To US$102

Establishment Labs Holdings Inc. (NASDAQ:ESTA) saw its stock drop 17% last week after releasing earnings, despite revenues beating expectations by 2.7%. Analysts have updated their forecasts, maintaining revenue estimates but increasing per-share loss expectations, yet they still raised the average price target by 7.1% …

PROCEPT BioRobotics (NASDAQ:PRCT) CEO Larry Wood Purchases 23,900 Shares

PROCEPT BioRobotics CEO Larry Wood purchased 23,900 shares of company stock for approximately $498,315. The company recently reported better-than-expected revenue but a slightly wider loss per share, leading to mixed signals from analysts and a recent downgrade from Wells Fargo. PROCEPT BioRobotics also faces …

RxSight (RXST) offers to swap 4.08M underwater options for new awards

RxSight, Inc. has initiated an employee stock option exchange offer for up to 4,083,693 underwater options issued under its 2021 Equity Incentive Plan. Eligible U.S.-based employees can exchange options with exercise prices at or above $6.00 (or $10.00 for named executive officers) for new …

Medtronic (MDT) On New CE Mark Win And A Modest Undervalued View

Medtronic (MDT) recently received an expanded CE Mark for its Affera Mapping and Ablation System with Sphere-9 Catheter, leading to a recent positive share price momentum despite longer-term declines. The stock is considered modestly undervalued at $87.16 against a fair value of $90.37, supported …

ADAPTHEALTH CORP. : LEERINK PARTNERS CUTS TARGET PRICE TO $7 FROM $12

Leerink Partners has reduced its target price for AdaptHealth Corp. (AHCO) shares from $12 to $7. This change reflects an updated outlook from the investment firm regarding the company's valuation. The article, sourced from Reuters, provides this key financial adjustment.

Teledyne to Acquire Varex Imaging Corporation

THOUSAND OAKS, Calif. & SALT LAKE CITY, August 10, 2026--(BUSINESS WIRE)--Teledyne Technologies Incorporated (NYSE:TDY) ("Teledyne") and Varex Imaging Corporation (NASDAQ:VREX) ("Varex") jointly announced today that they have entered into a definitive agreement under which Teledyne will acquire all of the outstanding common shares of …

Ceribell Receives FDA 510(k) Clearance for New AI-Driven Neurology Portal Enhancements to Improve EEG Interpretation

Ceribell announced it received FDA 510(k) clearance for AI algorithm enhancements to its Neurology Portal: Epileptiform Abnormality Detection and Artifact Reduction. These new features aim to improve EEG interpretation in critical-care settings by filtering out interference and highlighting abnormalities. The enhancements were developed based …

Dimensional Fund Advisors LP Has $8.67 Million Stake in OrthoPediatrics Corp. $KIDS

Dimensional Fund Advisors LP reduced its stake in OrthoPediatrics Corp. (NASDAQ:KIDS) by 12.2% in the first quarter, though it still holds 546,626 shares valued at $8.67 million. Institutional investors collectively own 69.05% of the stock. Analysts generally maintain a "Moderate Buy" rating for OrthoPediatrics, …

Procept BioRobotics CEO Larry Wood buys $498k in stock

PROCEPT BioRobotics CEO Larry Wood recently purchased 23,900 shares of the company's common stock for approximately $498,315, held indirectly through The Larry Wood Trust. This insider buying follows a period of stock momentum and occurs as the company reported a 19% increase in Q2 …

Steadtrust LLC Boosts Position in InMode Ltd. $INMD

Steadtrust LLC significantly increased its stake in InMode Ltd. (NASDAQ:INMD) by 251.9% in the second quarter, bringing its total holdings to 91,500 shares valued at $1.34 million. This move comes as InMode reported quarterly earnings per share that matched analyst expectations and revenue that …

Truist Securities Adjusts PT on Treace Medical Concepts to $5 From $4, Keeps Hold Rating

Truist Securities has raised its price target for Treace Medical Concepts (TMCI) from $4 to $5, while maintaining a "Hold" rating on the stock. This adjustment comes after Treace Medical Concepts recently increased its earnings guidance for the full-year 2026. The medical technology company …

Fluent Financial LLC Makes New $1.73 Million Investment in Abbott Laboratories $ABT

PROCEPT BioRobotics (PRCT) CEO adds 23,900 shares via trust purchase

PROCEPT BioRobotics Corp President and CEO Larry L. Wood, through The Larry Wood Trust, purchased 23,900 shares of common stock on August 7, 2026, at a weighted average price of $20.85 per share. Following this transaction, the trust indirectly holds 23,900 shares, and Wood …